Slow-freezing versus vitrification for human ovarian tissue cryopreservation
- 1.2k Downloads
Ovarian tissue can be cryopreserved prior to chemotherapy using either the slow-freezing or the vitrification method; however, the data on the equality of the procedures are still conflicting. In this study, a comparison of the cryo-damage of human ovarian tissue induced by either vitrification or slow-freezing was performed.
Ovarian tissue from 23 pre-menopausal patients was cryopreserved with either slow-freezing or vitrification. After thawing/warming, the tissue was histologically and immunohistochemically analyzed and cultured in vitro. During tissue culture the estradiol release was assessed.
No significant difference was found in the proportion of high-quality follicles after thawing/warming in the slow-freezing and vitrification group, respectively (72.7 versus 66.7 %, p = 0.733). Estradiol secretion by the ovarian tissue was similar between groups during 18 days in vitro culture (area-under-the-curve 5,411 versus 13,102, p = 0.11). Addition of Sphingosine-1-Phosphate or Activin A to the culture medium did not alter estradiol release in both groups. The proportion of Activated Caspase-3 or ‘Proliferating-Cell-Nuclear-Antigen’ positive follicles at the end of the culture period was similar between slow-freezing and vitrification.
Slow-freezing and vitrification result in similar morphological integrity after cryopreservation, a similar estradiol release in culture, and similar rates of follicular proliferation and apoptosis after culture.
KeywordsHuman Ovarian tissue Cryopreservation Slow-freezing Vitrification
Conflict of interest
The authors declare that they have no conflict of interest.
- 21.Smitz J, Dolmans MM, Donnez J, Fortune JE, Hovatta O, Jewgenow K et al (2010) Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update 16(4):395–414PubMedCentralPubMedCrossRefGoogle Scholar
- 46.Kaya H, Desdicioglu R, Sezik M, Ulukaya E, Ozkaya O, Yilmaztepe A et al (2008) Does sphingosine-1-phosphate have a protective effect on cyclophosphamide- and irradiation-induced ovarian damage in the rat model? Fertil Steril 89(3):732–735. doi: 10.1016/j.fertnstert.2007.03.065 PubMedCrossRefGoogle Scholar
- 47.Hancke K, Walker E, Strauch O, Gobel H, Hanjalic-Beck A, Denschlag D (2009) Ovarian transplantation for fertility preservation in a sheep model: can follicle loss be prevented by antiapoptotic sphingosine-1-phosphate administration? Gynecol Endocrinol 25(12):839–843. doi: 10.3109/09513590903159524 PubMedCrossRefGoogle Scholar